Summary
Background: Rheumatoid arthritis (RA) patients may suffer cardiovascular (CV) events much more than the general population, and CV disease is the leading cause of death in patients with RA. Our hypothesis was that impaired function of endothelial progenitor cells may contribute to endothelial dysfunction and the clinical CV events of patients with RA. Methods: About 27 RA patients (9 males and 18 females) with an active disease and 13 healthy subjects who served as the control group (nine males and four females) were enrolled to this prospective study. The ability to grow in culture colonyforming units of endothelial progenitor cells (CFU-EPCs) was measured, as well as their endothelial function using highresolution ultrasonography of the brachial artery, and levels of C reactive protein (CRP) in the serum. For statistical analysis, we used the Student's t-test. Results: As a group, patients with RA were older (P < 0.0001), had severe endothelial dysfunction (P<0.0001), with impaired ability to grow CFU-EPCs (P<0.0001), and a higher inflammatory state (P ¼ 0001). No difference was observed in BMI. All RA patients had an active disease (DAS28 3.9 6 0.9) for 9.2 6 6.5 years. The same differences were observed in both genders. Conclusions: Patients with RA had an impaired ability to grow EPCs and severe endothelial dysfunction. Inability to grow colonies of EPCs reflects the impaired regenerative capacity of patients with RA and may explain the endothelial dysfunction and the high CV event rate among patients with RA.
Background
RA is associated with a high rate of cardiovascular (CV) events, morbidity and mortality. [1] [2] [3] Retrospective studies showed that patients with RA are at increased risk (almost double) to develop acute myocardial infarction compared with the healthy population. 4 The high systemic inflammatory burden in RA seems to be an important mechanism that eventually leads to vascular inflammation, accelerated atherosclerosis and CV events. 5 Traditional CV risk assessment (the Framingham and the systemic coronary risk evaluation [SCORE]) actually underestimates the real risk to develop acute myocardial infarction or acute stroke, because these models do not incorporate the impact of systemic inflammation and the effect of inflammation on the lipid profile. 6 The European League Against Rheumatism Structural vascular disease estimated by the carotid intima thickness (IMT) was found to be increased in patients with RA. 10, 11 Endothelial function and arterial stiffness were also found to be impaired in patients with RA. [12] [13] [14] Endothelial function and dysfunction and vascular damage and repair are dependent on bone marrow derived endothelial stem cells. Studies have shown a correlation between endothelial function measured by the brachial artery method and the number and function of endothelial progenitor cells (EPCs) in the peripheral blood. EPCs number and function were reduced in patients with CV risk factors who also had endothelial dysfunction (measured by the brachial artery reactivity method) and among patients with atherosclerosis. 15 Patients with active RA had a decreased EPCs activity documented by flow cytometry. 16 EPCs can be isolated from circulating mononuclear cells. Laboratory evidence suggests that these cells express a number of endothelial-specific cell-surface markers and exhibit numerous endothelial properties. 15, 17 Studies that measured EPCs in RA patients used flow cytometry methods, reflecting the number of EPCs the peripheral circulation. However, no one studied their function and their ability to build colonies-a crucial event in regeneration of damaged blood vessels. We hypothesized that EPCs' function could be impaired and it might affect the endothelial repair in patients with RA.
Methods
The study was approved by the institutional review board of the Baruch Padeh Medical Center and every patient or a healthy volunteer had to sign a consent form before enrollment to the study. Only patients with an active long standing (more than 12 months) RA were recruited to the study. The selected patients did not have renal failure, type 2 or type 1 diabetes mellitus, hypertension, hypercholesterolemia, documented coronary artery disease, nor cancer. All patients were examined by an experienced Rheumatologist in the outpatient clinic and underwent a detailed assessment of disease activity using the disease activity scale (DAS28) (both, DAS-28 ESR and DAS-28 CRP). The DAS score already took into acount the swollen and tender joints. Forty subjects were recruited to this prospective study. Twenty-seven RA patients (9 males [mean age 54.4 6 11.1 years old] and 18 females [mean age 51.7 6 12.1 years old]) with an active RA (DAS28 was 4.2 6 0.8 for males, 3.9 6 1.0 for females).
The average time of disease activity was 9.2 6 6.3 years (males) and 9.2 6 6.9 years (females). About 13 healthy volunteers (9 men [mean age 32.8 6 3.1 years old] and 4 women [mean age 41.5 6 16.4 years old]) served as the control group. All signed a consent form before enrollment to the study.
Vascular studies
Flow mediated diameter percent change (FMD%): All measurements of brachial artery diameter and FMD% were performed in the morning, in a quiet and dark room and at controlled ambient temperatures between 20 C and 26 C. Studies were conducted after an overnight fast of at least 10 h (water was permitted), with the subject supine, and after 10 min of rest. The subject's right arm was comfortably immobilized in the extending position, allowing for ultrasound scanning of the brachial artery 5-10 cm above the antecubital fossa. In each examination, recording of vessel images was followed by inflation of a cuff to a supra-systolic pressure (40-50 mmHg above median blood pressure) for 5 min. Subsequently, the cuff was deflated and the brachial artery diameter was imaged and recorded for 3 min. An FMD% of more than 10% is considered a normal response. Lower than 10% FMD% reflect endothelial dysfunction, which means a high likelihood of developing a CV event in the future. Subjects with negative FMD% results (the artery is constricted after stress and not dilated as was expected) have the worst prognosis.
Growth of CFU-EPCs in culture
Peripheral-blood mononuclear cells formed distinct colonies on fibronectin-coated dishes ( Figure 1 ). We used a phase-contrast micrograph to detect an EPC characterized by a central cluster of rounded cells surrounded by radiating thin, flat cells (Â200). 18 It has been previously demonstrated that EPCs isolated in this fashion exhibit many endothelial characteristics, including expression of CD31, TIE2 and vascular endothelial growth factor receptor. 19 The investigator who performed the laboratory experiments was blinded to the patients' clinical data. Venous blood samples were drawn from an antecubital vein into ethylene diamine tetra acetic acid-containing tubes. Forty milliliters of blood were processed; peripheral blood mononuclear cells were isolated by Ficoll density-gradient centrifugation, washed twice in phosphate-buffered saline with 5% fetal bovine serum and resuspended in media (EndoCult basal media with supplements; StemCell Technologies, Vancouver BC Canada, for EPC colony forming assay). Cells were plated on human fibronectin-coated plates (BIOCOAT; Becton Dickinson Labware Bedford Mass) at a density of 5 Â 10 6 cells/well and incubated at 37 C in humidified 5% CO 2 . After 48 h, the non-adherent cells were re-plated onto fibronectin-coated 24-well plates at a density of 1 Â without associated emerging cells, the 'sunflower' image, was not counted as a colony. Colonies were counted manually in a minimum of eight wells by observers who were unaware of the subjects' clinical profiles.
Statistical analysis
Data are expressed as means 6 SE. Patients were compared with healthy controls in age, vascular reactivity (FMD%), the ability to grow endothelial progenitor stem cells in culture, CRP level and BMI with the use of a two-tailed unpaired Student's t-test. The v 2 test was used for comparisons of categorical variables.
Results

Formation of CFU-EPCs
We assessed whether EPCs' growth correlated with RA activity, studying also gender effect on these correlations. 
Vascular reactivity measurements
There was a significant difference in the vascular reactivity of patients with RA compared to the healthy controls. The FMD% of patients with RA was À5.8 6 7.7% vs. controls who had 20.36 8.2% (P < 0.0001). Men with RA had endothelial dysfunction with an FMD% of À9.4 6 6.8% vs. 15.0 6 8.6% (P < 0.0001) ( Table 1) , and women with RA had endothelial dys3.8function of À4.6 6 7.4% vs. 27.3 6 3.9% (P < 0.0001) ( Table 1) . Interestingly, females with RA had a higher BMI compared with healthy females (26.1 6 4.9 vs. 21.6 6 2.6, P ¼ 0.03), a phenomenon that was not found in men (25.4 6 3.2 vs. 27.1 6 3.8, P ¼ 0.326).
Discussion
Our study shows that patients with RA with a long standing disease had higher levels of inflammatory markers and an impaired ability to grow colonies of endothelial stem cells in culture along with severe endothelial dysfunction.
It has been shown that patients with RA tend to develop atherosclerosis at early stage of their inflammatory disease, with an increased intima media thickness and significantly lower levels of FMD%, which reflects an impaired nitric oxide bioavailability, leading to accelerated atherosclerosis through a nitric oxide dependent pathway. 20 These observations were done at an early stage of the disease, less than 12 months of RA disease activity, which may suggest an independent vascular pathway that leads to accelerated atherosclerosis. 21 Partial mechanistic explanation was found in a study that measured levels of asymmetric diendothemethyl arginine (ADMA), a competitive inhibitor to L arginine (the natural substrate of nitric oxide production through activated endothelial nitric oxide synthase), and found that ADMA levels were significantly higher in RA patients, and that these levels were inversely correlated with endothelial function of the patients (measured by the FMD% in the brachial artery method). 22 Another study found that patients with RA had an impaired lipid profile with high levels of total and low density lipoprotein cholesterol and very low high density lipoprotein cholesterol levels, altogether with endothelial dysfunction and high levels of inflammatory markers. 23 A genetic mechanistic pathway was suggested, through common genes that are involved in RA and in accelerated atherosclerosis. HLA-DRB1 alleles encoding a common sequence of amino acids (shared epitope alleles) have been associated with an increased incidence of erosions and extra articular manifestations of RA. It was found that patients with an increased incidence of CV events and endothelial dysfunction have the HLA-DrB1*04 shared epitope alleles, in particular, those who carry the HLA-DRB1*0404 allele. [24] [25] [26] A study from UK described an increased mortality risk among RA patients who carry the HLA-DRB1*0101/*0401 and 0404/*0404 genotypes. 26 It has been shown that in atherosclerotic processes there is a lack of EPCs, like in diabetes mellitus, coronary artery disease and depression, leading to endothelial function and eventually to atherosclerotic clinical syndromes including coronary artery disease and peripheral artery disease. 18 Impaired ability to grow colonies of stem cells is a long standing process that leads to CV disease and acute myocardial infarction, 19 which may also be associated with cerebral vascular disease leading to acute ischemic stroke. 27, 28 Endothelial damage ultimately represents a balance between the magnitude of injury and the capacity for repair. Inability to repair means lack of regenerative power, lack of vasculogenesis and a vicious cycle of endothelial damage. This impaired ability to grow colonies of EPCs in patients with RA could be due to several mechanistic pathways: a long standing process of oxidative stress, lack of nitric oxide activity, a self-perpetuating process of deterioration of the nitric oxide reservoir. Another explanation could be a continuous endothelial damage or dysfunction leads to an eventual depletion or exhaustion of a presumed finite supply of EPCs. 30 Interestingly, recent studies in animals have suggested that the exhaustion of stem cells may be an important determinant of a number of age-related conditions. [31] [32] [33] An inverse correlation between EPCs number and the Framingham risk score was found in patients at risk to develop CV events and both in long standing and early RA patients. 34 Studies that quantified the number of EPCs (CD34þ/CD133þ) in the peripheral blood of patients with RA using the flow cytometry method, found a significant negative correlation between EPCs and levels of pro-inflammatory cytokines (interleukin 1 and tumor necrosis factor a) and disease activity score in patients with seropositive RA. [35] [36] [37] A recent study found that EPCs (measured by flow cytometry) and FMD% (measured by the brachial artery method) were both impaired in patients with active RA, however, after 24 weeks of anti-tumor necrosis factor a treatment, levels of EPCs were restored in parallel with an improvement in endothelial function. 38 It has demonstrated that CD34þ cells count was lower in patients with RA, and their reactive oxygen species (ROS) level, expression of Toll-like receptor 3 and interleukin 1b expression were increased in comparison with healthy controls. 39 The same group has shown in another study that in patients with RA ROS level, mRNA expression of manganese superoxide dismutase, catalase and the expression of NOX2 were higher while glutathione peroxidase type 1 antioxidant enzymes level was significantly lower. 40 Both studies show the kink between inflammation, oxidative stress, the impaired antioxidant system and the impaired vascular responsiveness (endothelial dysfunction)-all lead to accelerated atherosclerosis in patients with RA. It is interesting to mention another study of our group where endothelial function was measured and compared with RA disease activity. Interestingly, the group of patients with the highest flow mediated percent change (FMD%) (who had a good endothelial function) had the lowest clinical RA scores and inflammatory laboratory parameters, which means that measuring endothelial function can estimate RA disease activity and severity, and also could be used as a practical tool for inflammatory activity score and as an early predictor of atherosclerosis in patients with RA. 41 
Study limitations
The small size of our population sample study and the age difference between patients with RA and healthy controls are limiting factors that should be considered, however, our results should encourage performing future prospective studies with larger populations at different age groups, and in different duration of disease activity, to make firm conclusions and to better understand the phenomenon of RA and atherosclerosis.
Summary
This is the first study that evaluated the function of EPCs, i.e. their ability to create colonies and to regenerate damaged blood vessels. Patients with RA had an impaired ability to grow CFUEPCs in culture and endothelial dysfunction. Inability to grow colonies of EPCs reflects the impaired regenerative capacity of patients with RA and may explain the mechanism of endothelial dysfunction, leading to the higher rate of CV events in patients with RA.
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